Stock market week-in-review for 5 large GI companies — Oct. 9-13

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Oct. 9 to Oct. 13, 2017.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $205.87 on Oct. 9
Peaked: $208.79 on Oct. 11
Closed: $205.72 on Oct. 13
Percent change between Oct. 9 and Oct. 13: -0.07 percent

2. Exact Sciences Corp.

Opened: $48.67 on Oct. 9
Peaked: $49.11 on Oct. 12
Closed: $47.13 on Oct. 13
Percent change between Oct. 9 and Oct. 13: -3.16 percent

3. Johnson & Johnson

Opened: $133.54 on Oct. 9
Peaked: $137.47 on Oct. 12
Closed: $136.52 on Oct. 13
Percent change between Oct. 9 and Oct. 13: 2.23 percent

4. Synergy Pharmaceuticals

Opened: $3.51 on Oct. 9
Peaked at open
Closed: $3.09 on Oct. 13
Percent change between Oct. 9 and Oct. 13: -11.96 percent

5. Valeant Pharmaceuticals

Opened: $14.50 on Oct. 9
Peaked: $14.65 on Oct. 10
Closed: $13.38 on Oct. 13
Percent change between Oct. 9 and Oct. 13: -7.72 percent

More articles on gastroenterology: 
GI leader to know: Dr. Josh Evans of Midwest Gastrointestinal Associates
What patients think about IBS-C — 8 survey insights
7 things to know about ACG’s next president, Dr. Irving Pike

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.